| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | T61871RKRI |
| InChI Key | JRNJNYBQQYBCLE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H21F2N5O4S |
| Molecular Weight | 441.46 |
| AlogP | 1.41 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 127.51 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Cyclin-dependent kinase 1 inhibitor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL384304 |
| DrugBank | DB08094 |
| EPA CompTox | DTXSID30225143 |
| FDA SRS | T61871RKRI |
| Guide to Pharmacology | 5707 |
| PDB | LIA |
| SureChEMBL | SCHEMBL2397067 |
| ZINC | ZINC000013983251 |